Abstract
PURPOSE: Preoperative chemoradiotherapy for advanced rectal cancer has been an important therapeutic tool to improve the long-term results of curative resection. It is not known whether preoperative chemoradiotherapy for advanced rectal cancer influences the perioperative course of immune parameters. METHODS: Thirty patients with rectal cancer underwent surgery with (study group, n = 15) or without (control group, n = 15) preoperative chemoradiotherapy (2 cycles of 5-fluorouracil, 45 Gy). Blood samples were taken before neoadjuvant therapy, preoperatively, and on Days 1, 2, and 5 after surgery. Cell numbers of lymphocyte subpopulations, granulocytes, monocytes, and natural killer cells were determined by flow cytometry; tumor necrosis factor-α and interleukin-6 serum levels were measured with enzyme-linked immunosorbent assay. RESULTS: Significant differences between study and control patients (P < 0.05) were detected regarding circulating interleukin-6 and tumor necrosis factor-α levels, with depression of the proinflammatory response to surgery in study patients. Similarly, granulocytosis and monocytosis after surgery were significantly lower in patients after neoadjuvant therapy. Furthermore, cell counts of total T lymphocytes, T helper cells, B lymphocytes, and natural killer cells were significantly reduced after preoperative chemoradiotherapy. This depression of cell-mediated immunity in study patients was even more pronounced after surgery. CONCLUSIONS: Preoperative chemoradiotherapy for advanced rectal cancer results in a significant preoperative and postoperative immune dysfunction as indicated by depression of lymphocyte subpopulations, monocytes, granulocytes, and proinflammatory cytokine release. These findings are of importance because increased perioperative morbidity and mortality rates have been observed after preoperative chemoradiotherapy.
Similar content being viewed by others
References
TE Read MS McNevin EK Gross et al. (2001) ArticleTitleNeoadjuvant therapy for adenocarcinoma of the rectum Dis Colon Rectum 44 513–522
C Gammà M Giunta F Fiorica L Pagliaro A Craxi M Cottone (2000) ArticleTitlePreoperative radiotherapy for resectable rectal cancer JAMA 284 1008–1015
M Wannenmacher C Herfarth (2000) ArticleTitleConfirmed findings on preoperative therapy of rectal carcinoma Chirurg 71 1440–1446
B Rau P Wust H Riess PM Schlag (2000) ArticleTitlePreoperative radio-chemotherapy in rectal cancer—actual treatment concepts Zentralbl Chir 125 356–364
L Påhlman B Glimelius (1990) ArticleTitlePre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial Ann Surg 211 187–195
T Holm LE Rutqvist H Johansson B Cedermark (1996) ArticleTitlePostoperative mortality in rectal cancer, treated with or without preoperative radiotherapy Br J Surg 83 964–968
T Holm T Singnomklao LE Rutqvist B Cedermark (1996) ArticleTitleAdjuvant preoperative radiotherapy in rectal cancer Cancer 78 968–976
M Dahlberg B Glimelius W Graf L Påhlman (1998) ArticleTitlePreoperative irradiation affects functional results after surgery for rectal cancer Dis Colon Rectum 41 543–551
. NIH consensus conference (1990) ArticleTitleAdjuvant therapy for patients with colon and rectal cancer JAMA 264 1444–1450
Y Francois CJ Nemoz J Baulieux et al. (1999) ArticleTitleInfluence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer J Clin Oncol 17 2396–2402
RJ Heald RDH Ryall (1986) ArticleTitleRecurrence and survival after total mesorectal excision for rectal cancer Lancet 17 1479–1482
A Markewitz E Faist C Weinhold et al. (1993) ArticleTitleAlterations of cell-mediated immune response following cardiac surgery Eur J Cardiothorac Surg 7 193–199
AM Eggermont EP Steller PH Sugarbaker (1987) ArticleTitleLaparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells Surgery 102 71–78
TW Lennard BK Shenton A Borzotta et al. (1985) ArticleTitleThe influence of surgical operations on components of the human immune system Br J Surg 72 771–776
JL Weese FD Ottery SE Emonto (1986) ArticleTitleDo operations facilitate tumor growth? An experimental model in rats Surgery 100 273–277
M Salo (1992) ArticleTitleEffects of anaesthesia and surgery on the immune response Acta Anaesthesiol Scand 36 201–220
Y Shigemitsu T Saito T Kinoshita M Kobayashi (1992) ArticleTitleInfluence of surgical stress on bactericidal activity of neutrophils and complications of infection in patients with esophageal cancer J Surg Oncol 50 90–97
A Laxamana MJ Solomon Z Cohen SM Feinberg HS Stern RS McLeod (1995) ArticleTitleLong-term results of anterior resection using the double-stapling technique Dis Colon Rectum 38 1246–1250
JC Goligher PW Lee J Macfie KC Simpkins DJ Lintott (1993) ArticleTitleExperience with the Russian model 249 suture gun for anastomosis of the rectum Dis Colon Rectum 36 873–880
WI Law KW Chu JW Ho CW Chan (2000) ArticleTitleRisk factors for anastomotic leakage after low anterior resection with total mesorectal excision Am J Surg 179 92–96
F Marusch A Koch U Schmidt et al. (2002) ArticleTitleProspective multicentre studies of colorectal carcinomas as comprehensive surgical quality assurance Chirurg 73 138–146
MG Jeschke SE Wolf MA DebRoy DN Herndon (1999) ArticleTitleThe combination of growth hormone with hepatocyte growth factor alters the acute phase response Shock 12 181–187
C Gabay I Kushner (1999) ArticleTitleAcute-phase proteins and other systemic responses to inflammation N Engl J Med 340 448–454
PI Tartter G Martinelli B Steinberg D Barron (1986) ArticleTitleChanges in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery Cancer Detect Prev 9 359–364
PI Tartter B Steinberg DM Barron G Martinelli (1987) ArticleTitleThe prognostic significance of natural killer cytotoxicity in patients with colorectal cancer Arch Surg 122 1264–1268
G Marchetti L Meroni S Varchetta et al. (2002) ArticleTitleLow-dose prolonged intermittent interleukin-2 adjuvant therapy J Infect Dis 186 606–616
E Faist A Mewes T Strasser et al. (1988) ArticleTitleAlteration of monocyte function following major injury Arch Surg 123 287–292
MW Wichmann R Zellweger C Williams A Ayala CM DeMaso IH Chaudry (1996) ArticleTitleImmune function is more compromised following closed bone fracture and hemorrhagic shock than hemorrhage alone Arch Surg 131 995–1000
J Brittenden SD Heys J Ross O Eremin (1996) ArticleTitleNatural killer cells and cancer Cancer 77 1226–1243
M Tisch F Heimlich V Daniel G Opelz H Maier (1998) ArticleTitleCellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer Otolaryngol Head Neck Surg 119 412–417
S Pasupathy KW Eu YH Ho F Seow-Choen (2001) ArticleTitleA comparison between open versus laparoscopic assisted colonic pouches for rectal cancer Tech Coloproctol 5 19–22
H Matsuoka A Nakamura T Masaki et al. (2002) ArticleTitlePreoperative staging by multidetector-row computed tomography in patients with rectal carcinoma Am J Surg 184 131–135
C Schinkel K Licht S Zedler S Schinkel D Fuchs E Faist (2001) ArticleTitlePerioperative treatment with human recombinant interferon-gamma Shock 16 329–333
AK Mels MG Statius Muller PA van Leeuwen et al. (2001) ArticleTitleImmune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma Br J Surg 88 539–544
MW Onaitis RB Noone M Hartwig et al. (2001) ArticleTitleNeoadjuvant chemoradiation for rectal cancer Ann Surg 233 778–785
E Faist M Wichmann C Kim (1997) ArticleTitleImmunosuppression and immunomodulation in surgical patients Curr Opin Crit Care 3 293–298
. Wadler (1991) ArticleTitleThe role of immunotherapy in colorectal cancer Semin Oncol 18 27–38
Author information
Authors and Affiliations
About this article
Cite this article
Wichmann, M.W., Meyer, G., Adam, M. et al. Detrimental Immunologic Effects of Preoperative Chemoradiotherapy in Advanced Rectal Cancer. Dis Colon Rectum 46, 875–887 (2003). https://doi.org/10.1007/s10350-004-6677-z
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6677-z